WallStSmart

High Tide Inc (HITI)vsPOMDOCTOR LIMITED American Depositary Shares (POM)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

High Tide Inc generates 76% more annual revenue ($720.47M vs $410.44M). HITI leads profitability with a -4.6% profit margin vs -90.2%. HITI earns a higher WallStSmart Score of 43/100 (D).

HITI

Hold

43

out of 100

Grade: D

Growth: 9.3Profit: 4.0Value: 5.0Quality: 3.5
Piotroski: 2/9Altman Z: 0.68

POM

Avoid

26

out of 100

Grade: F

Growth: 6.0Profit: 2.5Value: 5.0Quality: 4.5
Piotroski: 3/9Altman Z: -33.39

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HITI2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
32.8%10/10

Revenue surging 32.8% year-over-year

EPS GrowthGrowth
1532.0%10/10

Earnings expanding 1532.0% YoY

POM1 strengths · Avg: 10.0/10
Debt/EquityHealth
-0.9610/10

Conservative balance sheet, low leverage

Areas to Watch

HITI4 concerns · Avg: 2.8/10
Market CapQuality
$236.67M3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.173/10

Elevated debt levels

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-52.8%2/10

ROE of -52.8% — below average capital efficiency

POM4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$10.84M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : HITI

The strongest argument for HITI centers on Revenue Growth, EPS Growth. Revenue growth of 32.8% demonstrates continued momentum.

Bull Case : POM

The strongest argument for POM centers on Debt/Equity.

Bear Case : HITI

The primary concerns for HITI are Market Cap, Debt/Equity, Piotroski F-Score.

Bear Case : POM

The primary concerns for POM are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

HITI profiles as a hypergrowth stock while POM is a turnaround play — different risk/reward profiles.

HITI is growing revenue faster at 32.8% — sustainability is the question.

HITI generates stronger free cash flow (9M), providing more financial flexibility.

Monitor PHARMACEUTICAL RETAILERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

HITI scores higher overall (43/100 vs 26/100) and 32.8% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

High Tide Inc

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

High Tide Inc. is a vertically integrated company in the cannabis market in Canada, the United States and internationally. The company is headquartered in Calgary, Canada.

Visit Website →

POMDOCTOR LIMITED American Depositary Shares

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

Pomdoctor Limited, offers an online B2C portal to sell pharmaceutical products. The company is headquartered in Guangzhou, China.

Visit Website →

Want to dig deeper into these stocks?